SEC Form 4 reporting owner

Khan Najat

Khan Najat has filed 10 Form 4 transactions reported between December 22, 2025 and September 8, 2026, as CEO and President, Chief R&D Commercial Officer of RECURSION PHARMACEUTICALS, INC..

Name as filed: Khan Najat

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$807K

4 lines

Companies

with Form 4 filings

Latest transaction

Sep 8, 2026

transaction date

Roles and reported holdings

RXRXRECURSION PHARMACEUTICALS, INC.
Dec 22, 2025 – Sep 8, 2026
CEO and President, Chief R&D Commercial Officer
Held directly2,072,890 sh as of Sep 8, 2026 · Form 4
24 months: $807K sold

Transaction history

All 10 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 8, 2026	RXRXCEO and President	Open-market saleCode S · direct	22,408	$3.52	$79K@ $3.52	2,072,890	Form 4
Aug 17, 2026	RXRXCEO and President	Shares withheld for tax or exercise priceCode F · direct	80,498	$3.16	$254K@ $3.16	2,095,298	Form 4
Jun 5, 2026	RXRXCEO and President	Open-market saleCode S · direct	23,588	$3.58	$84K@ $3.58	2,175,796	Form 4
May 15, 2026	RXRXCEO and President	Shares withheld for tax or exercise priceCode F · direct	62,701	$3.04	$191K@ $3.04	2,199,384	Form 4
Mar 9, 2026	RXRXCEO and President	Open-market saleCode S · direct	28,298	$3.35	$95K@ $3.35	2,262,085	Form 4
Feb 17, 2026	RXRXCEO and President	Shares withheld for tax or exercise priceCode F · direct	14,280	$3.49	$50K@ $3.49	2,290,383	Form 4
Feb 6, 2026	RXRXCEO and President	Shares withheld for tax or exercise priceCode F · direct	10,364	$3.98	$41K@ $3.98	2,304,663	Form 4
Feb 6, 2026	RXRXCEO and President	Grant or awardCode A · direct	30,346	—	—	2,315,027	Form 4
Feb 6, 2026	RXRXCEO and President	Grant or awardCode A · direct	1,673,546	—	—	2,284,681	Form 4
Dec 22, 2025	RXRXChief R&D Commercial Officer	Open-market saleCode S · direct	124,403	$4.41	$549K@ $4.41	611,135	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.